News & updates

Janssen COVID-19 vaccine approved for use in EU on March 11

Created on:

March 11, 2021

The Janssen-Cilag International N.V COVID-19 vaccine has received authorization for emergency use by the European Medicines Agency (EMA) on March 11. Developed with fundamental support from the Molecular Virology group of the Leiden University Medical Centre (LUMC), it is the fourth vaccine to be administered in the European Union. The Netherlands has ordered more than 11 million vaccine doses.

Janssen first approached the LUMC Molecular Virology group in February of 2020. “A collaboration to support the development of the Janssen COVID-19 vaccine was proposed because they knew we had been studying coronaviruses for over 30 years”, says Professor Eric Snijder of the LUMC department of Medical Microbiology. Together, Snijder and Dr Marjolein Kikkert were responsible for leading the project. Snijder emphasizes that they were able to rapidly assist with the first phase of vaccine development and testing due to LUMC’s well-established research infrastructure: “not only did we have the experience, but we also had trained staff available and a state-of-the-art Biosafety Level 3 (BSL-3) laboratory”.

Read the full article

More news & updates

Successful return of international students at the LUMC during the first semester

March 9, 2022

Long have we awaited the moment that we could welcome international students at the LUMC again. Due to COVID, all student mobility was cancelled for over 1,5 years. And despite still having regulations in place, especially during the first semester of the academic year 2021-2022, it was refreshing to cautiously welcome international students again. We’re so pleased to see that the students who came to Leiden had a fun, meaningful and above all, educational experience. In a questionnaire, they’ve given us an insight into how they experienced student mobility during these strange times.

Dr. Jeremia J. Pyuza: From Scientific Collaboration to Community Impact in Tanzania

June 16, 2024

In the third edition of our “Faces Behind LUMC Global” interview series Dr. Jeremia J. Pyuza, a medical doctor and laboratory scientist, tells us the inspiring story of his journey from Tanzania to the Netherlands. Through his passion for research, he is committed to making an impact within rural and urban communities of his home country Tanzania.

Jogchum Beltman: From Tropical Doctor in Malawi to Gynecologist-Oncologist in Leiden

July 13, 2024

In the fourth edition in our “Faces Behind LUMC Global” series, Dr. Jogchum Beltman, a gynecologist-oncologist at LUMC brings us back to the early days of his career as a tropical doctor in Malawi and his current work as a medical specialist. A story about his experiences and the challenges he faced in this exciting field.